Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)
China flag China · Delayed Price · Currency is CNY
14.10
-0.31 (-2.15%)
Sep 10, 2026, 3:04 PM CST

SHE:300519 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
266.78265.13267.54270.28351.37320.77
Other Revenue
0.230.230.120.110.120.11
267.01265.36267.66270.4351.49320.88
Revenue Growth
1.76%-0.86%-1.01%-23.07%9.54%13.35%
Cost of Revenue
150.69163.14177.89160.03169.81145.29
Gross Profit
116.32102.2289.77110.37181.68175.58
Selling, General & Admin
34.8138.2641.543.6450.6149.27
Research & Development
13.2413.3512.6215.1315.5513.52
Other Operating Expenses
4.974.353.53.434.264.22
Operating Expenses
52.8255.7657.7461.5170.8666.85
Operating Income
63.546.4632.0348.87110.82108.73
Interest & Investment Income
18.1116.7623.5522.9814.0923.03
Other Non Operating Income (Expenses)
-9.66-0.01-0.01-0.02-0.01-0.01
EBT Excluding Unusual Items
71.9663.255.5771.83124.9131.74
Gain (Loss) on Sale of Assets
--0-0.07-0.29--0.71
Asset Writedown
0.37-0.04-0.010.020-0.02
Other Unusual Items
0.270.271.511.60.70.95
Pretax Income
72.663.4357.0173.16125.6131.96
Income Tax Expense
10.589.226.628.816.7817.68
Net Income
62.0254.2150.3964.36108.82114.28
Net Income to Common
62.0254.2150.3964.36108.82114.28
Net Income Growth
9.20%7.58%-21.70%-40.86%-4.78%15.46%
Shares Outstanding (Basic)
159159163161160161
Shares Outstanding (Diluted)
159159163161160161
Shares Change
-2.16%-1.91%1.03%0.54%-0.58%0.83%
EPS (Basic)
0.390.340.310.400.680.71
EPS (Diluted)
0.390.340.310.400.680.71
EPS Growth
11.61%9.68%-22.50%-41.18%-4.23%14.52%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
89.4365.4548.2337.3109.78127.64
Free Cash Flow Per Share
0.560.410.300.230.690.79
Dividend Per Share
0.3000.3000.3000.4000.5000.600
Dividend Growth
0%0%-25.00%-20.00%-16.67%0%
Gross Margin
43.56%38.52%33.54%40.82%51.69%54.72%
Operating Margin
23.78%17.51%11.97%18.07%31.53%33.88%
Profit Margin
23.23%20.43%18.83%23.80%30.96%35.62%
Free Cash Flow Margin
33.49%24.66%18.02%13.80%31.23%39.78%
EBITDA
77.5261.246.9763.64124.88121.59
EBITDA Margin
29.03%23.06%17.55%23.54%35.53%37.89%
D&A For EBITDA
14.0214.7414.9314.7714.0512.86
EBIT
63.546.4632.0348.87110.82108.73
EBIT Margin
23.78%17.51%11.97%18.07%31.53%33.88%
Effective Tax Rate
14.58%14.53%11.61%12.03%13.36%13.40%
Revenue as Reported
265.36265.36267.66270.4351.49320.88